Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009136
Filing Date
2023-05-10
Accepted
2023-05-10 16:30:57
Documents
57
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gbio-20230331x10q.htm   iXBRL 10-Q 1000514
2 EX-10.1 gbio-20230331xex10d1.htm EX-10.1 93556
3 EX-10.2 gbio-20230331xex10d2.htm EX-10.2 915656
4 EX-10.3 gbio-20230331xex10d3.htm EX-10.3 381361
5 EX-31.1 gbio-20230331xex31d1.htm EX-31.1 7618
6 EX-31.2 gbio-20230331xex31d2.htm EX-31.2 8135
7 EX-32.1 gbio-20230331xex32d1.htm EX-32.1 5103
8 EX-32.2 gbio-20230331xex32d2.htm EX-32.2 5082
9 GRAPHIC gbio-20230331xex10d1001.jpg GRAPHIC 11550
  Complete submission text file 0001558370-23-009136.txt   5697168

Data Files

Seq Description Document Type Size
10 EX-101.SCH gbio-20230331.xsd EX-101.SCH 29442
11 EX-101.CAL gbio-20230331_cal.xml EX-101.CAL 35020
12 EX-101.DEF gbio-20230331_def.xml EX-101.DEF 116288
13 EX-101.LAB gbio-20230331_lab.xml EX-101.LAB 249926
14 EX-101.PRE gbio-20230331_pre.xml EX-101.PRE 209809
51 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20230331x10q_htm.xml XML 578811
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39319 | Film No.: 23907012
SIC: 2834 Pharmaceutical Preparations